Results 51 to 60 of about 5,770 (235)

Reproductive Wastage in Recurrent Partial Hydatidiform Mole: A Clinical Dilemma. [PDF]

open access: yes, 2013
Recurrent partial Hydatidiform mole is an extremely rare clinical entity which represent a part of the gestational trophoblatic neoplasia spectrum. Since the first case was reported by Honore.
Ashmita, D   +3 more
core  

Gestational trophoblastic neoplasia after miscarriage with dilatation and curettage with normal histological findings [PDF]

open access: yes, 2017
Gestational trophoblastic neoplasia may develop after a molar, term, ectopic pregnancy, or an abortion. The diagnosis of gestational trophoblastic neoplasia can be made solely based on changes in human chorionic gonadotropin levels without pathologic ...
Bağcı, Mustafa   +5 more
core   +1 more source

Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition?

open access: yesPLoS ONE, 2016
BackgroundGestational Trophoblastic Disease comprises a group of benign and malignant disorders that derive from the placenta. Using Leventhal's Common-Sense Model as a theoretical framework, this paper examines illness perception in women who have been ...
Valentina E Di Mattei   +8 more
doaj   +1 more source

A review on management of gestational trophoblastic neoplasia

open access: yesJournal of Family Medicine and Primary Care, 2020
Background: The rare presence of malignant cancerous cells afar any type of pregnancy is known as gestational trophoblastic neoplasia (GTN). GTN are benign lesions which mostly happen due to the activity of extravillous trophoblast cells and the ...
Seyedeh Reyhaneh Yousefi Sharami   +1 more
doaj   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox   +46 more
wiley   +1 more source

Optimizing Maternal Microbiome: Role in Improved Conception and Pregnancy Outcome

open access: yesReproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
Maternal microbiome optimization: Minimized risk and simple corrective steps. ABSTRACT Purpose To evaluate the role of optimizing the maternal microbiome in improving pregnancy outcomes, focusing on preconception and early gestation, and to propose practical diagnostic and preventive strategies, particularly in low‐ and middle‐income countries (LMIC ...
Eytan R. Barnea   +7 more
wiley   +1 more source

Placenta Percreta Presenting with Delayed Haematuria [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Placenta percreta presents as life threatening complications with bladder invasion. A condition of placenta invading urinary bladder presented with differential diagnosis of gestational trophoblastic neoplasia on imaging and responded to chemotherapy. A
Vinayak Gorakhanath Wagaskar   +2 more
doaj   +1 more source

Gestational Trophoblastic Neoplasia in the 1990s [PDF]

open access: yes, 2013
Major advances have been achieved during the past 40 years in the epidemiology, etiology, pathology, endocrinology, immunology, diagnosis, and treatment of molar pregnancy (MP) and gestational trophoblastic neoplasia (GTN).
Goldstein, Donald Peter
core  

Placental site trophoblastic tumor: a case report and review of the literature [PDF]

open access: yes, 2015
We present a case of a gravida 1 para 1 woman, who presented with an 11- month history of amenorrhea after cesarean delivery. The patient was taking birth control pills at the time of presentation.
Cunha, Teresa Margarida   +2 more
core   +1 more source

Whole‐genome paternal uniparental disomy identified through prenatal single‐nucleotide polymorphism‐based cell‐free DNA screening

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 1, Page 73-78, January 2026.
ABSTRACT Objective Prenatal single‐nucleotide polymorphism (SNP)‐based cell‐free DNA (cfDNA) screening can identify genome‐wide paternal uniparental disomy (GW‐UPDpat), including cases with complete hydatidiform mole with a coexisting fetus (CHMCF), those with placental mesenchymal dysplasia (PMD) and those with a mosaic/chimeric GW‐UPDpat syndrome ...
P. Benn   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy